Log in to save to my catalogue

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker p...

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f6f174b37dfb419b9a0109faee06b961

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile

About this item

Full title

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile

Publisher

England: BioMed Central

Journal title

Alzheimer's research & therapy, 2021-07, Vol.13 (1), p.134-134, Article 134

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Understanding the changes that occur in the transitional stage between absent and overt amyloid-β (Aβ) pathology within the Alzheimer's continuum is crucial to develop therapeutic and preventive strategies. The objective of this study is to test whether cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF, struct...

Alternative Titles

Full title

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f6f174b37dfb419b9a0109faee06b961

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f6f174b37dfb419b9a0109faee06b961

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-021-00863-y

How to access this item